Value through Innovation27 July 2016

Clinical Study Results

  • Alovudine - HIV Infections
    Clinical Study Number 1211.1
    Study Indication HIV Infections
    Product Alovudine
    Generic Name Alovudine
    Lab Code
    Clinical Phase IIa
    Study Title

    Randomised, Double Blind, Placebo-controlled Dose Ranging Trial to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure

    Study Document Trial synopsis 1211.1 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.